Certican

Certican (Everolimus) is an oral medication used to prevent organ rejection after transplants. This immunosuppressant helps manage the body's immune response to transplanted organs.

Certican is primarily used to prevent organ rejection in patients who have undergone liver or kidney transplants. It works by suppressing the immune system to reduce the risk of the body attacking the new organ. Everolimus is often part of a broader treatment plan that includes other immunosuppressants and careful monitoring by healthcare professionals.

Common effects of Certican may include headaches, nausea, and fatigue. Some users also report mild digestive issues or changes in blood pressure. These effects can vary widely among individuals and are not experienced by everyone taking the medication.

Certican should be handled with care, especially regarding dosage and administration. It is important to follow the guidance of a healthcare professional to avoid potential complications. Regular monitoring is essential to manage any adverse effects and ensure the medication's effectiveness.

Certican may interact with other medications, particularly those that affect the liver's enzyme systems. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain foods may also influence the effectiveness of Certican.